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Resumo
Objetivo: Este estudo avaliou através de imagens radiográficas digitais, a ação de biomateriais de quitosana e de 
cloridrato de quitosana, com baixo e alto peso molecular, utilizados na correção de defeitos ósseos de tamanho crítico 
(DOTC)em calvária de ratos. Material e método: DOTCs com 8 mm de diâmetro foram criados cirurgicamente 
na calvária de 50 ratos Holtzman. Em 10 animais o defeito foi preenchido foram preenchidos com coágulo 
sanguíneo (controle negativo). Os 40 animais restantes foram divididos de acordo com o biomaterial utilizado no 
preenchimento do defeito (quitosana de baixo peso e de alto peso molecular, e cloridrato de quitosana de baixo e 
de alto peso molecular), e foram avaliados em dois períodos experimentais (15 e 60 dias), totalizando 5 animais/
biomaterial/período de avaliação. Resultado: A avaliação radiográfica foi feita utilizando duas radiografias digitais 
do crânio do animal: uma tomada logo após o defeito ósseo ser criado e a outra no momento do sacrifício. Nessas 
imagens, foi avaliada a densidade óssea radiográfica inicial e a final na área do defeito, que foram comparadas. As 
análises na densidade óssea radiográfica indicaram aumento da densidade óssea radiográfica dos DOTCs tratados 
para todos os biomateriais testados, em ambos os períodos. Resultados semelhantes foram encontrados no grupo 
controle. Conclusão: Conclui-se que os biomateriais de quitosana testados não foram capazes de aumentar a 
densidade radiográfica em DOTC realizados em calvária de ratos.
Descritores: Materiais biocompatíveis; regeneração óssea; quitosana; quitina; interpretação de imagem 
radiográfica assistida por computador.
Abstract
Objective: This study evaluated, using digital radiographic images, the action of chitosan and chitosan hydrochloride 
biomaterials, with both low and high molecular weight, used in the correction of critical-size bone defects (CSBD’s) 
in rat’s calvaria. Material and method: CSBD’s with 8 mm in diameter were surgically created in the calvaria of 
50 Holtzman rats and these were filled with a blood clot (Control), low molecular weight chitosan, high molecular 
weight chitosan, low molecular weight chitosan hydrochloride and high molecular weight chitosan hydrochloride, 
for a total of 10 animals, which were divided into two experimental periods (15 and 60 days), for each biomaterial. 
The radiographic evaluation was made using two digital radiographs of the animal’s skull: one taken right after the 
bone defect was created and the other at the moment of the sacrifice, providing the initial and the final radiographic 
bone density in the area of the defect, which were compared. Result: Analysis of radiographic bone density indicated 
that the increase in the radiographic bone density of the CSBD’s treated with the proposed biomaterials, in either 
molecular weight, in both observed periods, where similar to those found in control group. Conclusion: Tested 
chitosan-based biomaterials were not able to enhance the radiographic density in the CSBD’s made in rat’s calvaria.
Descriptors: Biocompatible materials; bone regeneration; chitosan; chitin; radiographic image 
interpretation computer-assisted.
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INTRODUCTION
Different techniques have been used aiming to correct 
critical-size bone defects (CSBD’s) in the cranium-facial region1, 
and the autogenous bone graft has become the most foreseeable 
and best documented method, considered as the gold-standard 
for correcting this type of defect2. However, this technique is 
associated with morbidity and pain, and it is limited with regard 
to the quantity of available donor material, as well as the necessity 
of creating an additional surgical site3.
To minimize these problems, new biomaterials have been 
developed, in an attempt of substituting the bone tissue without 
the necessity of creating a donor site4. To successfully execute the 
expected biological functions, the biomaterial should portray 
characteristics such as biocompatibility, foreseeability, clinical 
applicability, biological and chemical stability, good mechanical 
properties and must be low cost5,6.
Recently, researchers have shown interest in new materials 
that enhance bone formation, especially natural biopolymers, 
such as chitosan, which seems to have potential for bone-defect 
repair7. Chitosan is a hydrophilic biopolymer obtained from 
chitin, the second abundant polysaccharide in the nature after 
cellulose in annual production quantity8. Its primary natural 
source is the crustacean carapace and it presents a great variety 
of applicability, mainly in the textile, food and cosmetics 
industry. However, its main application is in the production of 
chitosan, a biocompatible and biodegradable substance that has a 
considerable amount of applicability, among them, in agriculture, 
in the food industry and recently, in the medical field9-11.
The chitosan-based biomaterials are being tested in the 
treatment of periodontal bone defects7,12 and a considerable variety 
of clinical studies realized to promote their use have not reported any 
inflammatory or allergic reaction after its implantation, injection, 
topical application or ingestion into the human body13. Chitosan’s 
chemical structure, similar to that of hyaluronic acid, reinforces 
this biopolymer’s indication for use as a repairing and healing 
agent, because chitosan is capable of increasing the inflammatory 
cell’s function as leucocytes and macrophages, promoting cellular 
organization and acting in ample wound repair14,15.
Although literature shows studies using chitosan as a biomaterial, 
research realized so far fails to characterize the chitosan used, not 
relating factors such as the molecular weight or concentration, 
harming the reproducibility of the studies and the influence of these 
parameters in the results obtained, thus opening more fields for 
studies regarding its properties. Therefore, in vivo studies focusing 
on all these characteristics are still needed in literature.
The present study radiographically evaluated the action of 
chitosan and chitosan hydrochloride biomaterials, with both low 
and high molecular weight, used in the correction of critical-size 
bone defects (CSBD’s) in rat’s calvaria.
MATERIAL AND METHOD
The study protocol was approved by the Ethics in Animal 
Research Committee of the Araraquara Dental School 
(UNESP,  Brazil), Process # 24/2006, in compliance with the 
applicable ethical guidelines and regulations of the International 
Guiding Principles for Biomedical Research Involving Animals 
(Geneva, 1985).
1. Biomaterials
To attain chitin, shrimp crust obtained from São Paulo 
State – Brazil –  south coast producers were stocked in freezers 
and washed in running water to remove impurities, crushed in 
a blender, deproteinized with 1 M sodium hydroxide solution 
and demineralized with 0.25 M hydrochloric acid, providing the 
powdered chitin.
For the attainment of chitosan, 5 g of chitin were suspended 
in 200  mL of a 40% 1 M NaOH solution, at the temperature of 
115 °C, during 6 hours and under constant stirring, promoting its 
deacetylation, with a final DA of 80%. This reaction was made in 
duplicity, to produce chitosan with different molecular weights, 
and for that in one of the reaction wells it was introduced Sodium 
Borohydride (NaBH4) to reduce chain depolymerization, producing 
a high molecular weight chitosan (4 × 105 kDa). In the reaction well 
where this substance was not used, chitosan presented a molecular 
weight of 9 × 104 kDa. The final products were re-suspended in 
an acetic acid 1% solution for 24 hours, filtered and neutralized by 
NH4OH. This reaction induced the chitosan precipitation, which 
was washed in distilled water, filtered, and dried, and so it was 
available for the biomaterials production.
A water-soluble chitosan derivate, chitosan hydrochloride, 
was also produced, by diluting both high and low molecular 
weight chitosan in a 0.1 M acetic acid solution, dialyzing them 
against a 0.2 M NaCl solution for 72 hours and freezing the 
samples in liquid nitrogen. Freezed samples were lyophilized, 
originating chitosan hydrochloride sponges.
For attainment of the gels, chitosan was diluted at a 
concentration of 20  mg/mL in 0.1 M acetic acid solution. The 
chitosan hydrochloride sponges were diluted in water, at the same 
concentration, for the attainment of their gels. All solvents were 
sterile, as so as the hardware used. It were produced four different 
biomaterials (gels) – High molecular weight chitosan (HMWC), 
Low molecular weight chitosan (LMWC), High molecular weight 
chitosan hydrochloride (HMWCH) and Low molecular weight 
chitosan hydrochloride (LMWCH), with a medium pH of 6.0, 
and a stable viscosity at 37 °C. All gels were exposed to ultra-violet 
radiation for a period of 12 hours before in vivo application.
2. Study Design
In this study, 50 Rattus norvegicus rats were used (Holtzmann, 
albinus, male, adults, and weighing around 350 g). The rats were 
kept at a special facility at São Paulo State University - UNESP, 
Araraquara Dental School, in a room with a 12 hours light/dark 
cycle and temperature between 22 and 24 °C. They were fed 
regular rodent chow and water ad libitum.
Each animal was randomly assigned to one of five 
experimental groups: Group C (control), Group HMWC, Group 
LMWC, Group HMWCH and Group LMWCH, according to the 
tested biomaterial. Each group of animals was divided into two 
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sub-groups for euthanasia at either 15 or 60 days post-operative, 
in a total amount of 5 animals/biomaterial/period of observation.
Animals were anesthetized by an intramuscular injection of 
xylazine (6 mg/kg body weight, Agner União S.A., São Paulo, 
SP, Brazil) and ketamine (70 mg/kg body weight, Laboratórios 
Calier S.A., Barcelona, Spain). After aseptic preparation, a 
straight incision was made in the scalp in the anterior region 
of the calvarium allowing reflection of a full-thickness flap. An 
eight millimeter in diameter CSBD was made with a trephine 
(3i Implant Innovations Inc., Saint-Laurent, Quebec, Canada) 
used in a low-speed hand piece under continuous sterile saline 
irrigation. In Group C, the surgical defect was filled with a blood 
clot only, and in the other groups, the defect was filled with the 
biomaterial that named the group. All defects were then covered 
by a collagen membrane (Genius-Baumer, São Paulo, SP, Brazil), 
cut with round edges and hydrated in sterile saline solution. Soft 
tissues were then repositioned and sutured to achieve primary 
closure (Vycril 4.0, Ethicon, São Paulo, SP, Brazil). Each animal 
received an intramuscular injection of 24,000 IU penicillin 
G-benzathine (Pentabiótico Veterinário Pequeno Porte, Fort 
Dodges Saúde Animal Ltd., Campinas, SP, Brazil), followed by 
a single oral gavage of Paracetamol (600 mg/kg liquid - Tylenol; 
McNeil-PPC, Ft. Washington, USA) post-surgically.
It is important to emphasize that all bone defects were made 
by the same trained operator, who also checked the consistency 
of the defects (i.e. the complete removal of the host bone in the 
whole area of the critical size bone defect).
3. Radiographic Bone-density – Image Acquisition
For the radiographic evaluation, two digital radiographs of the 
CSBD filled with the biomaterial were taken, one radiography taken 
immediately after the surgery (initial radiography), and the second 
taken at the moment the animal was sacrificed after 15 or 60 days 
(final radiography). To make the radiographs, it was used 
complementary metal-oxide semiconductor (CMOS) equipment 
(Schick Technologies Inc., Dialom Dental Products, Long Island 
City, NY), which was positioned parallel to the surface of the 
created bone defect and this method was standard for all animals 
using a positioner. The vertical long axis of the implant positioned 
perpendicularly to the central X-ray beam and parallel to the 
sensor at 40-cm focus-object distance. The X-ray unit was operated 
at 70 KVp, 10 mA, and 0.3 seconds (Expectro 70×, Dabi Atlante, 
Ribeirão Preto, SP, Brazil). Image resolution was 635 ppi (pixels per 
inch), the size of the image was 900 × 641 dpi and the pixel size was 
40 μm. Images (Figure 1) were stored in the TIFF (Tagged Image 
File Format) without compression (8 bits with 600 dpi resolution).
4. Image Analysis
The radiographic bone density in the defects was determined 
by the analysis of gray levels inside the CSBD, in an area 
containing, in average, 35.000 pixels. This area was selected since 
it represented the full area of a 8-mm (in diameter) circular area, 
determining that the whole defect would be assessed, in all cases, 
standardizing the region that was measured. This analysis was 
Figure 1. Radiographic aspect of the 8 mm critical size bone defect (CSBD) made in rats calvaria (→).
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done by a blinded evaluator using the image-analysis software 
Image Tool 2.03 (UTHSCA, San Antonio, Texas, EUA), which 
provided the gray scale average and standard deviation in these 
pre-determined region by means of a histogram graph. The 
average gray level of the evaluated region was divided by the value 
of a metallic standard, inserted in all radiographic acquisitions, 
to compensate minimal differences among radiographs, since the 
density of the metallic standard was similar in all specimens16,17.
5. Statistical Analysis
The Kolgomorov-Smirnov test was used to verify data 
distribution, and data from radiographic bone density were 
analyzed statistically by analysis of variance (ANOVA), followed 
by Tukey post test, or using paired t test when 1 x 1 comparison 
were made. Significance level was set at 5%. Comparisons between 
the different groups and periods were done.
RESULT
The results obtained (Figure 2) indicated that, in the initial 
images, all defects presented statistically similar radiographic 
densities. In the final images, all final results were statistically 
equal in the early period of observation (15 days), but in the late 
period of observation (60 days), both Control and LMWC groups 
differed from LMWCH group (p < 0.05 – ANOVA, followed by 
Tukey test).
In the early period of observation (15 days), with the exception 
of the LMWC and HMWC groups, tested biomaterials presented 
a statistically significant (p < 0.01 – paired t test) increase of the 
radiographic bone density in the evaluated area, when comparing 
the initial and final images, as well as the Control group. At the 
60-day period of observation, with the exception of the Control 
and LMWC groups, no statistically-significant increase or 
decrease could be seen.
DISCUSSION
The biomaterials tested in this study presented considerably 
poor results, as none of them were capable of significantly increase 
the radiographic bone density in the CSBD area in comparison to 
the control group.
In bone cavities grafting materials normally delay the 
healing process, since they need to be replaced, incorporated 
or eliminated, with the aim of promoting bone repair, and 
this process begins with an inflammatory activity (variable, 
depending on the biomaterial) which evolves to the resolving 
of the defect18. Our findings in this study corroborate what we 
have already reported before, with no significant bone formation 
following chitosan and chitosan hydrochloride gels application in 
CSBDs, and defects repaired by connective tissue, with variable 
degrees of inflammation19.
Literature is controversial in relation to chitosan-based 
biomaterials attainment and their usage results. These 
biomaterials are capable of influencing all tissue reparation stages 
in experimental animal models18. In the inflammatory stage, 
the chitosan’s astringent properties are independent from the 
conventional healing cascade. In vivo, this polymer can stimulate 
the proliferation of fibroblasts and modulate the migration of 
neutrophils and macrophages, thus modifying the subsequent 
repair processes such as fibroplasias and tissue neoformation20.
Chitosan polymers have been tested in periodontal defects 
treatment not demonstrating the stimulation of important 
allergic or inflammatory reactions after its implantation, topical 
injection or ingestion7,12,13. In 2007, Asikainen  et  al.21 evaluated 
the biocompatibility of chitosan fibers and bioactive glass-based 
biomaterials implanted in the subcutaneous tissue of rats. They 
related the formation of a moderate inflammatory infiltration 
from the initial period, which was maintained even after the 
bioactive glass was absorbed, indicating that probably this 
reaction was caused by the chitosan fibers. Over a long period 
a moderate chronic inflammatory infiltrate continued to be 
evident. It is important to say that this inflammation, although 
necessary in the beginning of the regeneration process, delays 
and even inhibits the new bone formation18.
Literature has stated that chitosan and its derivates are capable of 
activate macrophage activity and that they can initiate inflammatory 
reactions. In 2005, Mori  et  al.22 evaluated the mechanism by 
which chitosan and its derivates could cause macrophages 
activation. Authors compared pure chitin, high-molecular-weight 
chitosan and low-molecular-weight chitosan placed in peritoneal 
macrophage cell cultures, and concluded that, in vivo, all the 
substances induced the activation of the primary histocompatibility 
complex I and II, where the low-molecular-weight chitosan was 
the one with lowest activation property. They concluded that the 
cellular activation alterations can, in a certain way, accelerate the 
tissue repair. However, if the damage is very severe or prolonged, it 
can cause a chronic inflammatory process, which will impede more 
complex regenerative processes, and could lead to a miscarriage in 
bone formation, which would be an explanation for our results, 
with no advantage for chitosan-based material over the blood clot. 
Figure 2. Relative radiographic bone density in the defect area (%) 
and their standard deviation. (**) Difference between the initial and 
the final values, in the same group and period, p < 0.01, Paired t test. 
(*) Difference between the groups, in the same period of observation, 
in the final radiographic bone density, p < 0.05 – ANOVA – Tukey Test.
316 Spin-Neto, Coletti, Freitas et al. Rev Odontol UNESP. 2012; 41(5): 312-317
The fact that the an increase in the bone density did not occur in 
the CSBD’s filled with the evaluated biomaterials, at least from what 
was radiographically observable, may have occurred due to either 
the biomaterial’s own characteristics, a reaction of rat’s body to the 
presence of this biomaterials, or even due to the bone defect type 
utilized. 
Bone defects can be regenerated whenever there are cells and 
original element tissue that can reposition, or can be repaired by 
the substitution of the injured tissue with another filling or support 
tissue. Bone is a tissue that presents a unique potential to restore 
its original structure, within certain limitations, considering that 
the reconstruction in the original organizational level occurs in 
sequence and exactly repeats the bone’s development and growth 
pattern. In this way, the autogenous graft is the most complete 
among all other grafting materials due to its osteoconductor, 
osteoinductor and osteogenic properties23.
As demonstrated above, literature has related some articles 
where the use of chitosan gel was favorable to bone-defect 
regeneration. However, the parameters of the studied biomaterial 
were not always delimited, and so information concerning the 
concentration, molecular weight and sterilization method were 
lacking. In this study, despite all the factors relating to the gel’s 
attainment being well delimited and described in the methodology, 
the molecular weight of the chitosan and chitosan-hydrochloride 
gel did not lead to significant modifications in the biological 
properties of the biomaterials tested and none of these 
biomaterials or their variations contributed to the increase of the 
radiographic bone density in the CSBD’s created, and, therefore, 
its indication is not advisable.
CONCLUSION
Based on the limitations of the model that was used and 
considering the presented results, it is concluded that none of 
the biomaterials utilized in the study significantly increased 
radiographic bone density in the CSBD’s, when compared to 
the blood clot alone, and the molecular weight did not seem to 
interfere in the results in a relevant manner. These biomaterials 
need to be submitted to further studies before they can be safely 
and positively used in tissue engineering.
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